Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.
As the world celebrated International Day of Persons with Disabilities (PwD) on December 3, corporate India has kept up with efforts to make workplaces more inclusive and accessible. Organisations across sectors are taking initiatives such as equipping offices with practical work tools like Braille-friendly and voice-enabled lifts and screen readers. While inclusion has gained pace, only 11.3 per cent (or 3.4 million out of 30 million) Indians with disabilities have jobs.
A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.
Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.
A glance back at some of the important ups and down Indian Inc faced in 2018.
The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.
Indian American physicians and entrepreneurs, who invested an estimated $25 million in Dr Akshay Desai's Universal Health Care Group Inc, are seething in anger after the company filed for bankruptcy. "The crook", as the investors and friends call Dr Desai today, has gone underground. Aziz Haniffa reports
.jpg)
The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.
The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.
These vaccines have not yet been approved by the World Health Organization
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
.jpg)
The company's US subsidiary, Lupin Pharmaceuticals Inc has launched its Ciprofloxacin for oral suspension in the US market in the strengths of 5 g/100 mL (250mg/5 mL) and 10 g/100 mL (500 mg/5 mL), Lupin said in a statement.
Glenmark said it along with its US-based partner has got the US health regulator's nod to manufacture and market two oxycodone products, used for treating moderate to severe pain, in the American market. The company's US arm, Glenmark Generics Inc and Lehigh Valley Technologies (LVT) have received US Food and Drug Administration nod for Oxycodone immediate release capsules, the company said in a filing to the Bombay Stock Exchange.
Has Steve Jobs' handpicked successor inherited the magic touch or is Apple's winning streak coming to an end?
In a major blow to Nirav Modi, a bankruptcy court in the US has rejected a petition of the fugitive diamond merchant and two of his associates, seeking dismissal of fraud allegations against them by the trustee of three companies they previously owned indirectly.
Many corporations extended benefits to same-sex couples well before the law was overturned.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
Software developers who tried on an Apple Watch for the first time on Friday predicted a rush of new apps over the next few months.
Take a look at the 10 biggest IT deals ever.
Here's how she is linked to the most talked about Oscars speech of the year.
Shares of hospital operators, health services providers and insurers rallied broadly
The first new product to be developed and introduced under Chief Executive Officer Tim Cook's reign is a wearable device
We bring you this excerpt from Shaili Chopra's book, When I was 25.
The market breadth ended weak on the BSE with 2,086 shares declining and 893 shares advancing.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances